Literature DB >> 12794406

Methodologic quality and genotyping reproducibility in studies of tumor necrosis factor -308 G-->A single nucleotide polymorphism and bacterial sepsis: implications for studies of complex traits.

Dixie L Peters1, Robert C Barber, Elizabeth M Flood, Harold R Garner, Grant E O'Keefe.   

Abstract

OBJECTIVE: Studies of genetic associations with common diseases, such as between cytokine gene polymorphisms and severe bacterial sepsis, have reached conflicting conclusions. Failure to follow methodologic standards may have contributed to discordant findings. The -308 G-->A transition in the tumor necrosis factor-alpha promoter has been genotyped by a variety of methods. Based on our observation of genotyping inaccuracies, we sought to determine whether published studies followed a series of acceptable methodologic standards and whether failure to follow the standard of genotyping reproducibility could lead to erroneous conclusions about gene-disease associations.
DESIGN: Systematic review and reanalysis of banked genetic material. We applied a published series of seven methodologic standards to five reports of the association between this variant and bacterial sepsis. We then studied the accuracy of restriction fragment length polymorphism for the -308 site using DNA from a cohort of injury victims.
SETTING: Surgery research laboratory.
MEASUREMENTS AND MAIN RESULTS: We observed that methodologic quality was not uniform and that reproducibility of genotyping was infrequently met. In our subjects, we found that 4 of 46 heterozygotes analyzed by restriction fragment length polymorphism were actually GG-homozygotes (9% misclassified) according to alternative genotyping methods.
CONCLUSIONS: Failure to confirm genotype may have led to conclusions that this polymorphism is not associated with sepsis or outcome. Our observations have implications for the conduct and evaluation of studies of complex genetic disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794406      PMCID: PMC1383771          DOI: 10.1097/01.CCM.0000065190.24116.A4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

Review 1.  Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

Authors:  R D Allen
Journal:  Mol Immunol       Date:  1999 Oct-Nov       Impact factor: 4.407

2.  Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing.

Authors:  A Alderborn; A Kristofferson; U Hammerling
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

3.  Clinical epidemiological quality in molecular genetic research: the need for methodological standards.

Authors:  S T Bogardus; J Concato; A R Feinstein
Journal:  JAMA       Date:  1999-05-26       Impact factor: 56.272

4.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.

Authors:  J P Mira; A Cariou; F Grall; C Delclaux; M R Losser; F Heshmati; C Cheval; M Monchi; J L Teboul; F Riché; G Leleu; L Arbibe; A Mignon; M Delpech; J F Dhainaut
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

5.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

Authors:  M A Palmatier; A M Kang; K K Kidd
Journal:  Biol Psychiatry       Date:  1999-08-15       Impact factor: 13.382

6.  Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Authors:  C F Terry; V Loukaci; F R Green
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men.

Authors:  T Keso; M Perola; P Laippala; E Ilveskoski; T A Kunnas; J Mikkelsson; A Penttilä; M Hurme; P J Karhunen
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

8.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 9.  Inherited variability of tumor necrosis factor production and susceptibility to infectious disease.

Authors:  J C Knight; D Kwiatkowski
Journal:  Proc Assoc Am Physicians       Date:  1999 Jul-Aug

10.  Tumor necrosis factor gene polymorphism and septic shock in surgical infection.

Authors:  G J Tang; S L Huang; H W Yien; W S Chen; C W Chi; C W Wu; W Y Lui; J H Chiu; T Y Lee
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

View more
  11 in total

Review 1.  Assessing the quality of case-control association studies on the genetic basis of sepsis.

Authors:  Sally H Vitali; Adrienne G Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

2.  Collagen type III alpha 1 polymorphism (rs1800255, COL3A1 2209 G>A) assessed with high-resolution melting analysis is not associated with pelvic organ prolapse in the Dutch population.

Authors:  Sabrina L Lince; Leon C van Kempen; Jeroen R Dijkstra; Joanna IntHout; Mark E Vierhout; Kirsten B Kluivers
Journal:  Int Urogynecol J       Date:  2014-04-24       Impact factor: 2.894

3.  Assessment of systematic effects of methodological characteristics on candidate genetic associations.

Authors:  Badr Aljasir; John P A Ioannidis; Alex Yurkiewich; David Moher; Julian P T Higgins; Paul Arora; Julian Little
Journal:  Hum Genet       Date:  2012-10-25       Impact factor: 4.132

4.  Biomarkers of sepsis.

Authors:  John C Marshall
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury.

Authors:  Pascual Martínez-Lucas; Jerónimo Moreno-Cuesta; Dolores C García-Olmo; Francisco Sánchez-Sánchez; Julio Escribano-Martínez; Ana Cuartero del Pozo; Máxima Lizán-García; Damián García-Olmo
Journal:  Intensive Care Med       Date:  2005-07-09       Impact factor: 17.440

Review 6.  A systematic review of the quality of genetic association studies in human sepsis.

Authors:  Martin Fraser Clark; Simon Victor Baudouin
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

7.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Hum Genet       Date:  2009-02-01       Impact factor: 4.132

8.  STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  PLoS Med       Date:  2009-02-03       Impact factor: 11.069

9.  STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

Review 10.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement.

Authors:  Julian Little; Julian P T Higgins; John P A Ioannidis; David Moher; France Gagnon; Erik von Elm; Muin J Khoury; Barbara Cohen; George Davey-Smith; Jeremy Grimshaw; Paul Scheet; Marta Gwinn; Robin E Williamson; Guang Yong Zou; Kim Hutchings; Candice Y Johnson; Valerie Tait; Miriam Wiens; Jean Golding; Cornelia van Duijn; John McLaughlin; Andrew Paterson; George Wells; Isabel Fortier; Matthew Freedman; Maja Zecevic; Richard King; Claire Infante-Rivard; Alex Stewart; Nick Birkett
Journal:  Eur J Epidemiol       Date:  2009-02-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.